Reach PLC (RCH)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 49.35 |
|---|---|
| 52-week range | 39.00 – 73.70 |
| Return, 1 month / 3 months | +18.9% / +13.9% |
| Return, 1 year / 3 years | −10.8% / −9.5% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 48.0% |
| Worst drawdown (1 year) | -38.7% |
| Average daily value traded | 61.70M GBX |
| Dividend yield | 12.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Reach plc is a British media company that publishes national and regional newspapers, magazines and digital news brands. Its titles include the Daily Mirror, the Daily Express and the Sunday People, alongside many local and regional newspapers serving communities across the United Kingdom and Ireland. The company earns money from advertising and newspaper sales, and it also runs digital news websites and related online services. Reach plc is based in the United Kingdom.
The shares are listed on the London Exchange in UK under the code RCH, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Reach PLC (RCH) trades on the London Exchange in UK. It last closed at GBX 49.35 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 2,362 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.8% and over the last three months it rose 13.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 27 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.7% | ||
| From 52-week high | -31.6% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 13.9% | ||
| 6-month return | -15.4% | ||
| 12-month return, skipping the last month | -25.0% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.7% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 61.70M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 12.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.8% |
|---|---|
| 1 month | +18.9% |
| 3 months | +13.9% |
| 6 months | −15.4% |
| 1 year | −10.8% |
| 3 years | −9.5% |
| 5 years | −76.5% |
Signals
| 50-day / 200-day average | 44.30 / 51.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jul 2026 | GBP 0.0144 |
| 30 Apr 2026 | GBP 0.0446 |
| 14 Aug 2025 | GBP 0.0288 |
| 1 May 2025 | GBP 0.0446 |
| 15 Aug 2024 | GBP 0.0288 |
| 9 May 2024 | GBP 0.0446 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.